Recent Headlines
Families of World War II Veterans Holds 2022 Fundraising Golf Tournament
Families of World War II Veterans held its annual golf tournament and fundraising event on Monday, October 24, at the award-winning Trinity Forest Golf Club in Dallas, Texas, the former home of the renowned AT&T Byron Nelson tournament. This is the organization’s biggest fundraising event... - November 12, 2022 - Careington
Are You Ready to Get Shroomed?
After a historical win for the war on drugs in Colorado, the state and the nation begins to look at ways to implement Magic Mushroom assisted therapy along with other plant medicine. We look at the facts behind this, and what it means for you. - November 11, 2022 - shroomed
PharmStars Announces Fall 2022 Startup Showcase Event
PharmStars, the pharma-focused accelerator for digital health startups, announces that its Fall 2022 Showcase Event will begin on November 8, 2022. The Showcase is the culmination of a 10-week startup accelerator program. At the Showcase Event, startups will make formal presentations to and meet... - November 08, 2022 - PharmStars
Biomed Industries, Inc. (“Biomed”) Today Announced the Closing of Its Merger with MedAware Systems, Inc., (“MedAware”)
Biomed Industries, Inc. (“Biomed”) today announced the closing of its merger with MedAware Systems, Inc., (“MedAware”), in which all issued and outstanding common shares of capital stock of MedAware will be exchanged for common stock of Biomed at a ratio of 5.33 shares of MedAware for 1 new common share of Biomed. The transaction valued at an aggregate of $20 million, to be paid by 2,259,170 common shares of Biomed. At present, Biomed has approximately 76,354,075 common shares issued. - November 07, 2022 - Biomed Industries, Inc.
Thrivous Launches Vitality Geroprotector Formula 2
Thrivous, the human enhancement company, has released Vitality Geroprotector Formula 2 with Mirtoselect® Blueberry Anthocyanin. Vitality is the advanced geroprotector supplement that Thrivous develops to enhance metabolism and cell function for better aging. Vitality combines geroprotector... - November 07, 2022 - Thrivous
Thaddeus Medical Customizable Cold-Chain iQ-Ler Now Available for Pre-Order
Cold Chain system is designed for storage, transportation and dispensary of temperature-sensitive medical therapeutics to eliminate all spoilage in cold-chain logistics and improve patient outcomes - November 03, 2022 - Thaddeus Medical
DistillerSR Launches New CuratorCR Capabilities to More Dynamically Manage and Reuse Evidence-Based Research
CuratorCR Knowledge Center Provides Alternative to Elsevier’s QUOSA Virtual Library as Its Sunset Date Looms. - October 31, 2022 - DistillerSR
Gallant Announces Hiring of John Klacking, Ph.D. as Chief Business Officer
Furthering its regenerative medicine therapeutics research and development, animal biotech company Gallant welcomes a pioneer in the biotech space. - October 25, 2022 - Gallant
Huntington Study Group Announces Results from the HD-Net Assessment on the State of Care for Huntington’s Disease in the United States
The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, is pleased to announce the results from the novel HD-Net survey, which examined the United States Huntington’s disease (HD) care delivery in a variety of clinic settings by HD specialists and non-specialists. - October 25, 2022 - Huntington Study Group
Minus K Technology Announces Announces Its Seventh U.S. Educational Giveaway of Vibration Isolators to Colleges and Universities
As Minus K celebrates their upcoming 30 years in business, they are giving away $25,000* dollars worth of passive mechanical patented superior performing negative-stiffness low-frequency vibration isolators to colleges in the United States. - October 25, 2022 - Minus K Technology Inc.
Vivisum Partners Publishes Strategic Analysis on the Ulcerative Colitis Marketplace
Among branded ulcerative colitis treatments, 84% of US gastroenterologists expect Zeposia to see an increase in prescription volume over the next 12 months, according to new research on the ulcerative colitis marketplace published by Vivisum Partners. Vivisum Partners has just published its... - October 25, 2022 - Vivisum Partners, LLC
New Market Insights on the Best MS Treatment Published by Vivisum Partners
What’s the best MS treatment according to neurologists? The question of how to assess the ideal drug to treat multiple sclerosis is difficult to answer. Neurologists determine which clinical attributes take higher priority for each patient. Vivisum Partners, LLC, a market research firm in... - October 24, 2022 - Vivisum Partners, LLC
ARA Breast Radiologist Goes All Pink to Emphasize Importance of Mammography
It’s Breast Cancer Awareness Month and many are working to bring attention to breast cancer and the importance of screening with mammography. However, Dr. Arthy Saravanan, head of the breast imaging section at ARA Diagnostic Imaging, is going the extra mile, in a bright pink car. Dr. - October 18, 2022 - ARA Diagnostic Imaging
Huntington Study Group Announces myHDstory™ Pilot Study: Making HD Voices Heard Has Reached Target Enrollment
The Huntington Study Group (HSG), a world leader in clinical research for Huntington’s Disease (HD) for over 30 years, is pleased to announce that the pilot study, Making HD Voices Heard, on the new online research platform, myHDstory™, has reached its enrollment target. “The HSG... - October 18, 2022 - Huntington Study Group
Kantify and Mcule Harness the Power of Data to Accelerate Drug Discovery
Kantify, using its AI technology for drug discovery and Mcule, with its compound sourcing platform, are collaborating to leverage data for better hit prediction. - October 17, 2022 - Mcule
Thrivous Releases Serenity Nightly Nootropic Formula 3
Thrivous, the human enhancement company, has released Serenity Nightly Nootropic Formula 3 with KSM-66® Ashwagandha. Serenity is the advanced nootropic supplement that Thrivous develops to enhance relaxation, sleep, and next-day focus. Serenity combines nootropic nutrients with the highest... - October 14, 2022 - Thrivous
Huntington Study Group Enrolls First Participant for Its Observational Study to Test the Reliability of the Virtual Use of the Unified Huntington’s Disease Rating Scale
The Huntington Study Group (HSG), a world leader in conducting clinical trials for Huntington’s Disease (HD) for over 30 years, together with its Clinical Research Organization (“CRO”), the HSG Clinical Research, Inc., today announces the enrollment of the first participant of its... - October 12, 2022 - Huntington Study Group
Mirror Biologics, Inc. Announces Additional $20 Million Investment to Close Out $30 Million Series A Investment Round
Mirror Biologics, Inc., a clinical stage biopharmaceutical company today announced the completion of the final $20 million tranche of its $30 million Series A investment round with Bradbury Asset Management (Hong Kong), Limited. Bradbury provided an initial $10 million tranche for this round in... - October 11, 2022 - Mirror Biologics, Inc.
SYNG Pharmaceuticals Announces Issuance of Its Canadian Patent for Non-Hormonal Therapy for Endometriosis
SYNG Pharmaceuticals Inc. (SYNG), a Kingston, Ontario based women’s health biotech, is pleased to announce that on October 04, 2022, the Canadian Intellectual Property Office granted Canada Patent No. 2,903,608 titled, "Treatment of endometriosis, angiogenesis and/or endometrial lesion growth." - October 09, 2022 - SYNG Pharmaceuticals Inc.
Vivisum Partners' Research Finds New Ulcerative Colitis Drugs Provide Excitement to Gastroenterologists
Newly published research found that several new ulcerative colitis drugs currently in development are providing excitement among gastroenterologists eager to add additional medicines to their current treatment options. Based on a market analysis from Vivisum Partners, a market research and brand... - October 08, 2022 - Vivisum Partners, LLC
Tasly Pharmaceuticals to Exhibit at BioJapan 2022 -- Bio-Pharmaceutical Company to Join with Maryland-Based Organizations at Asia’s Premier Biotechnology Partnering Event
Tasly Pharmaceuticals will exhibit at BioJapan 2022, October 12-14 at PACIFICO Yokohama - October 05, 2022 - Tasly Pharmaceuticals, Inc.
Evidence Partners Rebrands as DistillerSR to Leverage Market Awareness of Its Core Literature Review Platform
The Company Also Bolstered Its Executive Team in Security, Product Management and Operations to Support Accelerating Growth - September 28, 2022 - DistillerSR
New Decentralized Clinical Trial (DCT) Patient Satisfaction and Participation Report
800 Current and Future Clinical Trial Participants Link Satisfaction and Willingness to Participate with Decentralized Strategies - September 21, 2022 - Life Science Strategy Group, LLC
Biomed Industries, Inc. to Acquire MedAware Systems, Inc. to Expand Its Artificial Intelligence Research for Drug Discovery in Alzheimer’s Disease
Biomed Industries, Inc. (“BIOMED” or the “Company”), has entered into a share exchange agreement to acquire all of the issued and outstanding shares of MedAware Systems, Inc. MedAware shares was valued at $1.50 per share and BIOMED’s share was valued at $8.00 per share. The transaction was valued at an aggregate of $18 million, to be paid in the form of 2,259,170 common shares of BIOMED. On the date of the Agreement, BIOMED has approximately 76,354,075 common shares. - September 21, 2022 - Biomed Industries, Inc.
MEDraysintell Publishes the 9th Edition of Its Nuclear Medicine Report & Directory
A set of three volumes (3,500 pages) with a description of 970 products, together with a comprehensive profile of 380 companies active around the world in the radiopharmaceutical industry. - September 16, 2022 - MEDraysintell
Appointments Made to the Sterile Compounding Expert Panel Announced by Pharmacy Stars
The Sterile Compounding Expert Panel (SCXP) was established by Pharmacy Stars on July 7, 2022. Pharmacy Stars executive leadership has appointed key members to serve on SCXP’s panel. They have joined in support of the organization’s mission to strengthen sterile compounding practices in... - September 12, 2022 - Pharmacy Stars, LLC
GENINVO Service Offering Custom Application Development
GENINVO is a leading provider of high-quality, innovative life science tools. GENINVO understand the business challenges of enterprises big and small. Whether you need short-term, focused design support or turnkey product development, GENINVO has the right tools to meet your needs with the help of... - September 07, 2022 - GenInvo, Inc.
AeroGo Awarded 2022-2023 Great Place to Work Certification™
AeroGo is proud to announce that the company has been Certified™ by Great Place to Work®. The prestigious award is based entirely on what current employees say about their experience working at AeroGo. Great Place to Work® is the global authority on workplace culture, employee... - September 01, 2022 - AeroGo, Inc.
Paras Biopharmaceuticals Finland Oy Has Been Identified as One of the "Fastest Growing Companies in the Nordic Biotechnology Therapeutics & Diagnostics Industry"
Paras Biopharmaceuticals is pleased to announce that the company has been identified as one of the Fastest Growing Companies in the Nordic Biotechnology Therapeutics and Diagnostics industry by Plimsoll Publishing UK. - September 01, 2022 - Paras Biopharmaceuticals Finland Oy
CABRI Announces Call for Proposals on Specialized Pro-Resolving Mediator Analytical Methods
The Cayman Biomedical Research Institute (CABRI) is offering research grants in amounts up to $100,000 to support essential research on specialized pro-resolving mediator (SPM) analytical methods. - August 26, 2022 - Cayman Chemical Company
Deadline Extended: CABRI Announces Undergraduate Fellowships and Scholarship Program
The Cayman Biomedical Research Institute (CABRI) is accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator. Applications will be accepted from August 22 until September 18, 2022. - August 26, 2022 - Cayman Chemical Company
Jillian Altizer Joins AeroGo as Human Resources Manager
Jillian Altizer Joins AeroGo as Human Resources Manager. - August 25, 2022 - AeroGo, Inc.
Pharma CI Conference Returns Next Month: Meet Hundreds of Industry Leaders at the Top Event for 15+ Years
Ready, set, engage! The Pharma CI USA Conference & Exhibition is back in person and ready to deliver the industry-leading experience that has made Pharma CI the gold standard event for more than fifteen years. The much-anticipated return happens this September 21-22 at the Newark Liberty... - August 18, 2022 - Pharma CI Conference
VMRD Begins Manufacturing Key Reagent for Detection of CWD by RT-QuIC
Veterinary Medical Research & Development (VMRD), Pullman, WA, has partnered with CWD Evolution, Fort Collins, CO, to provide state-of-the-art diagnostic reagents for detection of the abnormal prion associated with Chronic Wasting Disease (CWD). The control of CWD requires identification of... - August 09, 2022 - VMRD, Inc.
Peptineo, LLC Selected by EPA to Provide EPA Nationwide Coverage for Point of Care (POC) COVID-19 Testing
The Environmental Protection Agency (EPA), Cincinnati Acquisition Division (CAD), has awarded Peptineo LLC, an emerging aerospace, health services, and defense solutions company, a three-year Blanket Purchase Agreement (BPA) to support a comprehensive COVID-19 testing program in support of the... - August 07, 2022 - Peptineo
International Panel of Experts Provides Guidance on Key Questions in Risk Assessment of PFAS Chemicals
A new peer-reviewed report by a panel of scientists sheds new light on regulation and management of per- and polyfluoroalkyl substances (PFAS). SciPinion, which objectively engages the global scientific community to analyze the toughest scientific topics, today announced the publication of an... - July 19, 2022 - SciPinion
PharmStars Announces Spring 2022 Accelerator Graduates: 11 Digital Health Startups Have Successfully Completed PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Spring 2022 program. The graduates successfully completed the 10-week PharmaU program, which culminated with the Showcase Event held June 8-10 in Boston. The Showcase Event brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - July 12, 2022 - PharmStars
Pharmacy Stars’ New Sterile Compounding Quality Peer Network Aims to Fill the Role Once Held by the Now Discontinued CriticalPoint Peer Network
Pharmacy Stars to launch the Sterile Compounding Quality Peer Network with the goal of filling the vacated role of CriticalPoint’s Peer Network, an online forum designed to support 503A entities, their regulators, and their certifiers. The CriticalPoint Peer Network has been discontinued as of June 30, 2022, according to the CriticalPoint website. - July 11, 2022 - Pharmacy Stars, LLC
River Valley Relief Names Ryan Kenaga President
River Valley Relief (RVR), a family-owned medical cannabis cultivator located in Fort Smith, Arkansas makes some organizational changes and names new President. - July 08, 2022 - River Valley Relief
Global Cancer Technology Successfully Concludes Glioblastoma Pre-Clinical Animal Studies with Impressive Results
Global Cancer Technology, a San Diego, CA biotechnology company, has successfully completed animal testing with GCT.GLIO.1, a PI3K selective inhibitor that can cross the blood brain barrier and modulate immune cell function. The company will advance the compound to Phase 1 clinical trials as a next step. - July 08, 2022 - Global Cancer Technology
Don't Let Joint Pain Hold You Back
Adventist Health Simi Valley is Ventura County’s first Robotic Center of Excellence and provides the community with the latest joint-replacement techniques resulting in less pain, shorter hospital stays and quicker recoveries. - July 02, 2022 - Adventist Health
NF Sports Releases New "Immune Defense(TM)" Drink Mix
Nutrition Supplement Company Aims to Combat Weakened Immune Systems by Helping to Limit the Spread of Viruses at the Cellular Level. - June 30, 2022 - NF Sports
PharmStars Announces “Innovations in Real-World Evidence” Theme for Fall 2022 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, announces it is now accepting applications for its Fall 2022 cohort with the theme, “Innovations in Real-World Evidence.” - June 15, 2022 - PharmStars
Defined Bioscience Announces Formation of Scientific Advisory Board
Defined Bioscience, a life science tools company pioneering the development of next generation ingredients for cell culture, today announced the formation of its scientific advisory board (SAB). The SAB is comprised of a distinguished group of academic and industry experts who will advise the... - June 15, 2022 - Defined Bioscience Inc.
GENINVO Launches Its Latest Offering - Innovation as a Service
GENINVO, a leading provider of life science product and business solutions announced the launch of its new, on-demand service: Innovation as a Service. GENINVO has recognized various challenges the pharmaceutical industry faces, especially in the wake of the pandemic. The need to expedite clinical... - June 12, 2022 - GenInvo, Inc.
PharmStars Announces Showcase Pitch Event for Spring 2022 Cohort
PharmStars, the pharma-focused accelerator for digital health startups, announces the start of its Showcase Event on June 8, 2022. The digital health startups that participated in the 10-week accelerator program will make formal presentations to, and answer questions from, the pharma members of PharmStars. All of PharmStars’ seven members are participating in the Showcase Event. - June 08, 2022 - PharmStars
Period Tracking App, Femometer, Launches Discount and Offers in Celebration of 10 Million Users
Reproductive, period, and pregnancy tracking app, Femometer, is celebrating a milestone of 10 million users. Femometer is offering more than half-off the Prime Membership option, as well as select products purchased through the app. The celebratory discount will be available to users from the 1st of June to 8th of June. - May 31, 2022 - Lollipop Technology Hangzhou Ltd. Co.
Pharmaceutical Compliance Partners Selects Luke Forman, University of Notre Dame, for Summer Internship Program
Pharmaceutical Compliance Partners selected Luke Forman, a Science-Business major at University of Notre Dame, as its first summer intern. This is the inaugural year for Pharmaceutical Compliance Partners’ internship program, allowing students to learn about drug development, pharmaceutical compliance, and business operations of life sciences firms. - May 25, 2022 - Pharmaceutical Compliance Partners
Molekule Consulting Announces the Launch of E.U. - Based Operations
Molekule Consulting announces the launch of an E.U. - based business / Molekule Hub continuing their focus on the development of global strategy and advisory services for the biopharmaceutical sector. - May 24, 2022 - Molekule Consulting
Biopharma Industry Standout Robert Proulx Joins Advisory Board of Global Cancer Technology
Global Cancer Technology is developing innovative treatments for deadly diseases like cancer, with a current focus on glioblastoma and breast cancer. To date, Mr. Robert Proulx has held numerous Board positions, is a recognized thought leader in biopharma, and currently holds dual roles as the founder and CEO of Imagion Biosystems. - May 21, 2022 - Global Cancer Technology